Component configuration for an X-ray therapy component, X-ray therapy system and method for configuring an X-ray therapy system
A dual RFID transponder system ensures safe handling and identification of sterile X-ray therapy components, addressing the challenge of handling sterile components in non-sterile areas by maintaining sterility and enabling controlled X-ray therapy activation.
Patent Information
- Application Number
- JP2024528614
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-11-15
- Filing Date
- 2022-11-14
- Publication Date
- 2025-01-21
- Estimated Expiration
- 2042-11-14
AI Technical Summary
Existing solutions are inadequate for handling sterile X-ray therapy components in non-sterile areas during treatment planning and preparation stages, posing risks due to potential loss of component properties from excessive radiation exposure and the need for precise component identification and handling.
A dual RFID transponder system is employed, with one transponder on a sterile component within primary packaging and another on secondary non-sterile packaging, allowing safe handling and identification of components during treatment planning and preparation, ensuring sterility and enabling controlled activation of X-ray therapy equipment.
Facilitates safe and efficient handling of sterile components in both sterile and non-sterile environments, ensuring proper component identification and authorization for treatment, thereby improving treatment planning and preparation workflows.
Smart Images

Figure 0007618895000002 
Figure 0007618895000003 
Figure 0007618895000004
Abstract
Description
[Technical field]
[0001] The present invention relates to a component configuration for an X-ray therapy component, an X-ray therapy system, and an X-ray therapy system To configure It concerns the method. [Background technology]
[0002] For components used in the field of X-ray therapy, it is important to know if they have already been used, since multiple use in different systems and / or in different locations can be a risk for the patient. Generally, plastic components have only a limited resistance with respect to ionizing radiation, i.e. they can lose their guaranteed properties if the radiation dose is excessive. Furthermore, components with certain properties must be provided during the treatment planning and treatment preparation phase. It is known to mark medical components with radio frequency identification (RFID) transponders (RFID tags) to allow them to be uniquely identified.
[0003] WO 2009 / 052048 A discloses a system and method for providing radiation therapy to a patient. The system includes at least one component provided with an RFID tag, e.g. a patient positioning device for use when the patient is to receive radiation therapy. The at least one component is selected specifically for use with the patient. The RFID tag includes patient related information. The RFID tag is interrogated by a reader to generate a signal that is used by an associated computer system to verify the location and presence of the patient and components in the room where the treatment is to be performed. The system and method allows for the location of each patient, selected facility staff and all components for the treatment of a particular patient to be identified. Furthermore, the system and method allows for the time that the patient and / or staff and / or components have been present at a location for a particular treatment to be identified.
[0004] WO 2014 / 071337 A1 discloses a system and method for marking and tracking surgical instruments using radio frequency identification (RFID) tags. In general, the system and method allow surgical instruments to be tracked throughout their sale and sterilization process. In one example, the system includes an instrument tray configured to receive a plurality of surgical instruments, having a superior RFID tag mounted thereon that contains and / or allows access to information about the tray and each surgical instrument placed thereon. Each individual surgical instrument on the instrument tray can be fitted with a subordinate RFID tag that contains and / or allows access to information about the surgical instrument.
[0005] DE 102020104628 B3 discloses an applicator for intraoperative radiation therapy. The applicator comprises a receptacle for accommodating a radiation probe and an insertion opening for inserting the radiation probe into the receptacle. The insertion opening is sealed by a seal. Furthermore, there is a first machine-readable information storage unit, which is at least partially arranged in the seal portion in such a way that removing or destroying the seal renders the information storage unit unreadable.
[0006] In the field of x-ray therapy, there are only unsatisfactory solutions to the problem of handling sterile components (eg, applicators) in non-sterile areas during the treatment planning and treatment preparation stages. Summary of the Invention [Problem to be solved by the invention]
[0007] The invention is based on the object of improving the handling of sterile components for X-ray therapy for treatment planning and treatment preparation. [Means for solving the problem]
[0008] According to the invention, this object is achieved by a component arrangement for an X-ray therapy component having the features of claim 1, claim 2 11 An X-ray therapy system according to the present invention, 6 X-ray therapy system with the following features: To configure This is achieved by a method. Advantageous configurations of the invention emerge from the dependent claims.
[0009] One of the basic ideas of the invention is to place a (second) RFID transponder in or on a non-sterile secondary packaging in addition to the (first) RFID transponder (also called RFID tag) placed on or in the sterile component. The sterile component is in the primary packaging. In this case, the primary packaging and the sterile component can be moved and handled independently of the secondary packaging during the treatment planning and preparation phase. In particular, in the state supplied by the manufacturer, the sterile component is placed in the primary packaging, which is placed in the non-sterile secondary packaging. In the treatment planning, the (second) RFID transponder on the secondary packaging can be read by a (second) RFID reader. This is carried out in an operating device, in particular of an X-ray therapy system, which is in a non-sterile area of an operating room. Since the components remain sterilely packaged in the primary packaging, no sterility problems arise. The treatment planning is carried out in the operating device, for example by a doctor or any other specialist. The primary packaging may then be removed from the secondary packaging and the sterile component is transferred to a sterile area of the operating room where a (first) RFID transponder located on or in the component is read by a (first) RFID reader located on an X-ray therapy device of the X-ray therapy system, for example to prompt initiation of and / or unblocking of the X-ray source or X-ray radiation.
[0010] In particular, a component configuration for an X-ray therapy component is developed that includes an X-ray therapy component having a first RFID transponder, a primary packaging in which the component is sterile packaged, and a secondary packaging having a second RFID transponder disposed therein and / or thereon and into which the component packaged within the primary packaging is disposed.
[0011] Furthermore, in particular an X-ray therapy system has been developed, which comprises an X-ray therapy device having a holding device configured to hold and / or position at least one component in and / or on a patient, and an operating device configured to control the X-ray therapy device, wherein the X-ray therapy device comprises at least one first RFID reader configured to read data from and / or write data to a first RFID transponder arranged on or in the at least one component, and the operating device comprises at least one second RFID reader configured to read data from and / or write data to a second RFID transponder arranged in and / or on the secondary packaging.
[0012] In addition, X-ray therapy systems To configure A method is provided, where configuring the X-ray therapy system for each of the at least one component includes: a second RFID reader of an operating device of the X-ray therapy system is used to read data from a second RFID transponder disposed in and / or on a secondary packaging of the component and / or data is written to the second RFID transponder; a component sterile packaged in a primary packaging is removed from the primary packaging; and a first RFID reader of an X-ray therapy device of the X-ray therapy system is used to read data from a first RFID transponder of the component and / or data is written to the first RFID transponder.
[0013] The component configuration, the X-ray therapy system and the method allow for improved handling of the X-ray therapy components during the treatment planning and treatment preparation phase. In particular, the use of two RFID transponders, one on or in the secondary packaging and one on or in the component, also solves the problem that it is generally not possible to read an RFID transponder placed on or in a component when the component is in the packaged state, since the distance between the RFID transponder and the RFID reader is too large in some situations. Furthermore, the secondary packaging is spatially separable from the primary packaging and the sterile components, so that treatment planning and / or treatment preparation can be performed without the sterile components being on the (non-sterile) operating equipment of the X-ray therapy system.
[0014] In particular, the component is an X-ray therapy component, for example the component may be an applicator that is placed on an X-ray source during treatment and used for targeted administration and shielding of X-ray radiation.
[0015] In particular, the operating device itself is formed separately from the X-ray therapy device. However, the operating device and the X-ray therapy device are connected to each other by signals. In particular, the operating device comprises a control device for controlling the treatment of the patient with the X-ray therapy device. The data read out from the second RFID transponder are evaluated for the treatment planning, in particular in the operating device, in particular by the control device. In particular, here, the configuration parameters of the X-ray therapy device as a starting point can be created using the read out data.
[0016] Data read from and / or written to the RFID transponder includes, for example, the following data: status of use (e.g. used / unused / sterile), number of uses, date and time of surgery, radiation dose in Gy / min, name of hospital, name of doctor, name of medical physicist, etc.
[0017] The components of the operating device and / or the X-ray therapy device, in particular the control device or devices, can be designed individually or collectively as a combination of hardware and software, for example as program code executed by a microcontroller or microprocessor. However, the components can also be designed individually or collectively as Application Specific Integrated Circuits (ASICs) and / or Field Programmable Gate Arrays (FPGAs).
[0018] The X-ray therapy device comprises, for example, a holding device formed as a stand or includes a stand. In principle, however, the holding device can have different embodiments, for example formed as a holding arm or includes a holding arm. For example, such a holding arm can be arranged on the patient's bed. Furthermore, the X-ray therapy device comprises, in particular, an X-ray source, which is arranged on the holding device, in particular at the (distal) end of the stand or holding arm. An (X-ray) applicator can be arranged on the X-ray source as a component. Before a treatment with X-ray radiation from the X-ray source is performed, it is checked whether a first RFID transponder of a component envisaged for treatment, for example an applicator arranged on the X-ray source, is registered by the first RFID reader. Basically, the presence of some other component, for example a holding plate, etc., can be monitored and / or checked. The authorization for treatment, given, for example by putting the X-ray source into an operable state using a clearance signal or by releasing a blocking signal, is only given if the presence of the component is detected. Together, the first RFID transponder and the first RFID reader form in particular an interlock, which is used to monitor and ensure the operation of the X-ray source.
[0019] In particular, the primary packaging is a welded sleeve (peel pouch) or blister pack sealed with a sterile barrier (eg, a Tyvek® seal) within which the sterile components are placed.
[0020] In particular, the secondary packaging is a non-sterile packaging made of cardboard and / or paperboard. In particular, the secondary packaging is in the form of a box or a foldable box. For example, the second RFID transponder is arranged in the form of a label on the inner or outer surface of the secondary packaging and is, for example, glued to it. In particular, the primary packaging arranged inside the secondary packaging contains only one component. Expressed differently, each component is in particular assigned to a primary packaging and to a secondary packaging.
[0021] An embodiment provides that the first RFID transponder and / or the second RFID transponder provide unique component identification data. In particular, this is a unique serial number, in particular a UID (Unique Identifier). The component can then be unambiguously identified. The unique component identification data is in particular stored in a memory of the respective RFID transponder and can be retrieved therefrom by an RFID reader. For example, further information regarding the at least one component can be retrieved from a database by means of the unique component identification data.
[0022] An embodiment provides that the first RFID transponder is biocompatible, so that it can come into contact with the tissue of a patient without causing any damage. For this purpose, the first RFID transponder is embedded in, for example, glass or a suitable plastic.
[0023] An embodiment provides for the first RFID transponder to be sterilizable by a sterilization method such that the component having the first RFID transponder can be resterilized after a single use and therefore reused. For example, the sterilization method may include steam sterilization and / or gamma irradiation.
[0024] Examples of RFID transponders that may be used are given in the table below.
[0025] [Table 1]
[0026] An embodiment provides that the component is an applicator for X-ray therapy. The applicator is arranged for use at or on an X-ray source of an X-ray therapy system. In particular, the applicator serves to position tissue to be irradiated at a distance from the initial point of X-ray radiation (i.e. from the target) and to protect tissue not to be irradiated.
[0027] An embodiment provides that at least one first RFID reader is arranged on the holding device, for example a stand, in a connection area in which at least one component is or can be arranged on the holding device for use. This allows a communication link with the first RFID transponder to be established, especially even if the transmission power of the first RFID reader is limited. The arrangement of the first RFID reader and the constraints on the transmission power of the first RFID reader may ensure, in particular, that a component is not registered if it is not arranged in the connection area. In particular, this allows the provision of an interlock, in which the X-ray source and the X-ray radiation are only enabled to be activated if a specified component (or specified components) is arranged in the connection area. For example, the X-ray source may be enabled to be activated only when the applicator is arranged on the X-ray source. In that case, the connection area and the transmission power of the first RFID reader are selected such that the distance between the first RFID transponder and the first RFID reader is close enough that a communication link between them can be established and data can be read from the first RFID transponder only when the applicator is placed over the X-ray source within that area of the connection area.
[0028] An embodiment provides that permission for X-ray therapy is given if data from the first RFID transponder of at least one component includes at least one specified information. This can ensure that at least one component has specified characteristics (e.g., usage status, number of uses, specified type). As a result, erroneous and / or incorrect use can be avoided. For example, if it is determined that at least one piece of information is not present after reading the first RFID transponder, the use of the X-ray therapy device can be prevented. For example, the at least one piece of information can include a serial number and / or a model number, in particular a UID (unique identifier). For example, before using a component, it is possible to check whether the component has already been used (usage status) by reading and checking the corresponding information. Thus, information that the component has already been used (or is unused) can be stored in the memory of the first RFID transponder after each use (see the embodiment described below). Furthermore, it is possible to check, for example, whether the maximum number of uses has already been reached (number of uses). For this purpose, for example, after reading, the number of uses stored in the memory of the first RFID transponder can be compared with a maximum value. Taking into account the comparison result, a clearance signal for the X-ray source and / or the treatment is generated or not. An embodiment provides that after at least one component has been used, information is stored in the first RFID transponder, which information marks that at least one component has been used and / or includes the number of uses of the at least one component. In this way, the use of at least one component can be directly indicated. Thus, before using a component, it is possible to check whether the component has already been used by reading and checking the corresponding information. Furthermore, it is possible to check, for example, whether the maximum number of uses has already been reached. For this purpose, for example, after reading, the number of uses can be compared with the maximum value. Taking into account the comparison result, a clearance signal for the X-ray source and / or the treatment is generated or not.
[0029] An embodiment provides that the first RFID transponder is disabled after use and / or after a given number of uses. The first RFID transponder can be irreversibly marked in this way. This can limit the total number of uses of the component. For example, this is necessary when the material of the component, e.g. plastic, reaches the maximum permissible total dose of ionizing radiation. For example, irreversible destruction can be caused by generating a transmission pulse of a certain power that exceeds a suitable threshold, said transmission pulse leading to a thermal destruction (cutting and / or short-circuiting) of the conductor tracks in the first RFID transponder by the total amount of coupled energy. As a result, the first RFID transponder is no longer operational and cannot be read.
[0030] An embodiment provides that at least one component is sterilized after each single use. In this way, at least one component can be reused. In this case, the first RFID transponder has a sterilizable embodiment and undergoes sterilization together with the component. For example, the component and the first RFID transponder can be placed in a sterilization tray (or instrument tray) or in a peel pouch, which is then subjected to a sterilization method (for example steam sterilization or gamma sterilization). Before being placed in the sterilization tray or peel pouch, the component is reset to a "new" state by appropriately writing to the first RFID transponder, for example by changing a bit provided for this purpose. The secondary packaging remains outside the tray or peel pouch, so that the second RFID transponder is still readable and / or writable in the operating equipment for preparation and / or planning purposes. It is also possible to store the component in a non-sterile state in the secondary packaging after a single use and subsequent cleaning, and to sterilize it only when it is needed again. Basically, however, the procedure in this case is as described above. In particular, a component is marked as "unused" only immediately before it is placed into a tray or peel pouch.
[0031] The invention will now be explained in more detail based on preferred exemplary embodiments with reference to the drawings. [Brief description of the drawings]
[0032] [Figure 1] 1 illustrates a schematic diagram of an embodiment of a component configuration for an X-ray therapy component. [Diagram 2] 1 shows a schematic diagram of an embodiment of an X-ray therapy system. [Diagram 3] 1 shows a schematic flow chart of an embodiment of a method for configuring an X-ray therapy system. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0033] FIG. 1 shows a schematic diagram of one embodiment of a component configuration 1 for an X-ray therapy component 2 .
[0034] The component arrangement 1 comprises an X-ray therapy component 2 with a first RFID transponder 3. The first RFID transponder 3 is arranged in or on the component 2. In particular, the component 2 is designed as an applicator 20, which can be connected to an X-ray source at a connection area 21 (see FIG. 2). In particular, the first RFID transponder 3 is arranged in or near the connection area 21, whereby reading from and / or writing to the first RFID transponder 3 can be performed by an RFID reader arranged on the X-ray source.
[0035] The component configuration 1 also includes a primary packaging 4 in which the component 2 is sterilely packaged. For example, the primary packaging 4 can be a peel pouch or a blister pack sealed by a sterile barrier (e.g., Tyvek® film).
[0036] Additionally, component arrangement 1 includes a secondary packaging 5 having a second RFID transponder 6 disposed therein and / or thereon. Primary packaging 4 and the components to be sterile packaged therein are disposed within secondary packaging 5. For example, secondary packaging is in the form of a box or foldable box made from paperboard or cardboard. Secondary packaging 5 is non-sterile and serves to handle, protect during transport and store sterile components 2 within primary packaging 4.
[0037] The first RFID transponder 3 and / or the second RFID transponder 6 may provide unique component identification data 25. The unique component identification data 25 may in particular comprise a unique serial number (e.g. a unique identifier, UID). In this case, the unique component identification data 25 is stored in a memory of the RFID transponder 3, 6 and can be retrieved therefrom and made available as required.
[0038] The first RFID transponder 3 may be biocompatible, which allows contact between the first RFID transponder 3 and living tissue. For this purpose, the RFID transponder 3 may be encapsulated, for example, in (bio)glass or a suitable plastic.
[0039] The first RFID transponder 3 may be made sterilizable by a sterilization method. Suitable RFID transponders 3 for this purpose have already been indicated.
[0040] 2 shows a schematic diagram of an embodiment of an X-ray therapy system 10. The X-ray therapy system 10 includes an X-ray therapy device 11 having a holding device 12 configured to hold and / or position at least one component 2 in and / or on a patient. For example, the holding device 12 is in the form of or includes a stand. The X-ray therapy system 10 also includes an operating device 13 configured to control the X-ray therapy device 11.
[0041] At least one part of the holding device 12, in particular the part where the at least one component 2 may be placed, is within a sterile area 30 of the operating room. The remaining parts of the X-ray therapy system 10, in particular the manipulation device 13, are outside the sterile area 30, in a non-sterile area, and can therefore be more easily manipulated.
[0042] The X-ray therapy device 11 comprises a first RFID reader 14 configured to read data from and / or write data to a first RFID transponder 3 arranged on or in at least one component 2. In particular, the at least one first RFID reader 14 is arranged on the holding device 12 in a connection area 17 in which at least one component 2 is or can be arranged on the holding device 12 for use purposes. In particular, the RFID transponder 3 is arranged in the connection area 17 in which a component 2, in particular an applicator 20, is or can be arranged on an X-ray source 15 arranged on the holding device 12.
[0043] The operating device 13 includes a second RFID reader 16 configured to read data from and / or write data to a second RFID transponder 6 arranged in and / or on the secondary packaging 5.
[0044] Both the X-ray therapy device 11 and the operating device 13 include respective control devices (not shown), each having a computing device and a memory. For example, the computing devices each include a microprocessor and are configured to execute program codes stored in the memory. In particular, the control devices are configured to control the communication between the respective RFID readers 14, 16 and the RFID transponders 3, 6, to read and evaluate data from the respective RFID transponders 3, 6, in particular the unique component identification data 25, and / or to write data to said RFID transponders. In particular, the control device of the X-ray therapy device 11 thus provides an interlock functionality, so that the X-ray therapy device 11 can be operated or a treatment can be started only if at least one specified component 2 is correctly positioned and unused (sterile). In particular, this can ensure that the (unused / sterile) applicator 20 is placed on the X-ray source 15 before the X-ray source 15 is activated. Additionally, the functionality of other components of the X-ray therapy device 11, such as the X-ray source 15 and the holding device 12 for holding the applicator 20, may also be blocked or unblocked depending on whether the applicator 20 is on the X-ray source 15 or not. This prevents a used / non-sterile applicator 20 from being placed on or in the patient.
[0045] FIG. 3 illustrates an X-ray therapy system 10. To configure A schematic flow chart of an embodiment of the method is shown in Figure 3. In addition to Figure 3, reference is also made below to Figure 2.
[0046] To set up the X-ray therapy system 10, the following steps are performed for each of at least one component 2. However, the steps are described herein for only one component 2. Basically, however, the method can be performed for other components 2 as well. In particular, the component 2 is an applicator 20, which is placed on the X-ray source 15 of the X-ray therapy device 11 during X-ray therapy.
[0047] In the method 100, a second RFID reader 16 of the operating device 13 of the X-ray therapy system 10 is used to read data from and / or write data to a second RFID transponder 6 placed in and / or on the secondary packaging 5 of the component 2.
[0048] In particular, in this process, the unique component identification data 25 (e.g. unique identifier UID) is caused to be read from the second RFID transponder. A treatment can be prepared on the operating device 13 with the aid of the read data. For example, the type and characteristics of the applicator 20 for the treatment plan can be stored in the X-ray therapy system 10. Basically, multiple similar components 2 of different types (e.g. applicators of different shapes) can also be stored, and the used component 2 is selected therefrom just before a specific treatment (e.g. the shape of the applicator 20 is selected depending on the course of the operation).
[0049] In the method 101, a component 2, in particular an applicator 20, sterilely packaged in a primary packaging is removed from the primary packaging. If the primary packaging is placed in a secondary packaging 5, the primary packaging is removed from the secondary packaging 5 together with the component 2 disposed therein. In this case, the sterile packaged component 2 is removed from the primary packaging such that the sterility of the component 2 is not compromised in the process.
[0050] In the means 102, the first RFID reader 14 of the X-ray therapy device 11 of the X-ray therapy system 10 is used to read data from and / or data is written to the first RFID transponder 3 of the component 2, in particular the applicator 20. In particular, provision is made in the process for unique component identification data 25 (e.g. unique identifier, UID) to be read from the first RFID transponder 3. Furthermore, provision may be made in the process for data to be read out, said data including information regarding whether the component 2 has already been used or not.
[0051] The means 103 may ensure that the X-ray treatment is started if the data of the component 2, in particular the first RFID transponder 3 of the applicator 20, contains at least one specified information. In particular, the unique component identification data 25 (e.g. unique identifier, UID) is ensured in the process. Alternatively or additionally, a blocking signal may be generated if the data does not contain the at least one specified information. For example, the at least one specified information may comprise an usage state specifying that the component 2 must be unused. For example, a bit reserved for this may be checked. If the bit contains the specified information (unused), the treatment is started, otherwise it is not started.
[0052] The means 104 may then proceed to store information in the first RFID transponder 3 after use of the component 2, in particular the applicator 20, which information marks the component 2 as used and / or comprises the number of uses of the component 2. For this purpose, corresponding data are written into the memory of the first RFID transponder 3.
[0053] The means 105 may ensure that after use and / or after a given number of uses, the first RFID transponder 3 is disabled, for example by coupling a high transmission power (above a suitable threshold) which irreversibly destroys and / or short-circuits the conductor tracks of the first RFID transponder 3 due to the influx of thermal energy.
[0054] The means 106 may ensure that the component 2, in particular the applicator 20, is sterilised after one use. For this purpose the component 2 is for example placed in a sterilisation tray or a peel pouch, which in turn forms the primary packaging in particular after sterilisation. In this case, in particular the first RFID transponder 3 is provided with data written thereto immediately before sterilisation, said data comprising information marking the component 2 as unused and / or sterile. For example, bits previously changed (i.e. after use) may be reset again. The above-mentioned means may then be carried out again on the sterilised component 2.
[0055] The method described in the present disclosure improves the handling of components in radiation therapy. In particular, this may facilitate preparation and work in both non-sterile and sterile areas. This may improve and in particular facilitate treatment planning and treatment preparation. In particular, this improves workflow, since it allows quick and simple registration and / or writing of data relating to at least one component independently of each other in both non-sterile and sterile areas of the operating room. [Explanation of symbols]
[0056] 1 Component Configuration 2. Components 3. First RFID Transponder 4 Primary packaging 5 Secondary packaging 6 Second RFID transponder 10 X-ray Therapy System 11 X-ray therapy equipment 12 Holding equipment 13 Operating equipment 14 The First RFID Reader 15 X-ray source 16 Second RFID Reader 17 Connection Area 20 Applicator 21 Connection Area 25 Component Identification Data 30 Sterile Area 100~106 Means of Method
Claims
1. A component configuration (1) for an X-ray therapy component (2), comprising: an X-ray therapy component (2) having a first RFID transponder (3); a primary packaging (4) in which the components (2) are aseptically packaged; a secondary packaging (5) having a second RFID transponder (6) disposed therein and / or thereon, and into which the component (2) packaged in the primary packaging (4) is disposed; A component configuration (1) including:
2. 2. The component arrangement (1) according to claim 1, characterized in that the first RFID transponder (3) and / or the second RFID transponder (6) provide unique component identification data (25).
3. 3. The component arrangement (1) according to claim 1 or 2, characterized in that the first RFID transponder (3) is biocompatible.
4. 3. The component arrangement (1) according to claim 1 or 2, characterized in that the first RFID transponder (3) is sterilizable by a sterilization method.
5. 3. The component arrangement (1) according to claim 1 or 2, characterized in that the component (2) is an applicator (20) for X-ray therapy.
6. A method for configuring an X-ray therapy system (10), comprising the steps of: for each of at least one component (2) present in a component configuration (1) according to claim 1, configuring the X-ray therapy system (10) comprises: a second RFID reader (16) of an operating device (13) of the X-ray therapy system (10) is used to read data from a second RFID transponder (6) arranged in and / or on a secondary packaging (5) of the component (2) and / or said second RFID reader (16) is used to write data to said second RFID transponder (6); removing said component (2) from a primary packaging (4) that is sterilely packaged therein; a first RFID reader (14) of an X-ray therapy device (11) of the X-ray therapy system (10) is used to read data from a first RFID transponder (3) of the component (2) and / or said first RFID reader (14) is used to write data to said first RFID transponder (3); A method comprising:
7. 7. The method according to claim 6, characterized in that permission is given for the X-ray treatment if the data from the first RFID transponder (3) of the at least one component (2) contains at least one specified information.
8. 8. The method according to claim 6 or 7, characterized in that after use of the at least one component (2), information is stored in the first RFID transponder (3), which records the at least one component (2) as having been used and / or which includes the number of uses of the at least one component (2).
9. 8. Method according to claim 6 or 7, characterized in that the first RFID transponder (3) is disabled after use and / or after a predefined number of uses.
10. 8. The method according to claim 6 or 7, characterized in that the at least one component (2) is sterilized after a single use.
11. 1. An X-ray therapy system (10), comprising: - an X-ray therapy device (11) having a holding device (12) configured for holding and / or positioning at least one component (2) of the component arrangement (1) according to claim 1 or 2 in and / or on a patient; an operating device (13) configured to control the X-ray therapy device (11); Including, the X-ray therapy device (11) comprises at least one first RFID reader (14) configured to read data from and / or write data to a first RFID transponder (3) arranged on or in the at least one component (2) of the component arrangement (1), the operating device (13) comprising at least one second RFID reader (16) configured to read data from and / or write data to a second RFID transponder (6) arranged in and / or on a secondary packaging (5) of the component arrangement (1) according to claim 1 or 2, 8. An X-ray therapy system (10), configured according to a method according to claim 6 or 7.
12. 12. The X-ray therapy system (10) of claim 11, characterized in that the at least one first RFID reader (3) is arranged on the holding device (12) in a connection area (17) in which the at least one component (2) is or can be arranged on the holding device (12) in use.
Citation Information
Patent Citations
Programming of sterilized surgical instrument
JP2008246188A
Method for attaching RFID tag to medical surgical instrument
JP2023102237A